Vigil Neuroscience, Inc.
NASDAQ: VIGL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ivana Magovcevic-Liebisch
- Employees
- 69
- Headquarters
- Watertown, United States
- IPO year
- 2022
- Market cap
- $375.7M
- Website
- https://www.vigilneuro.com
Loading VIGL…
Loading profile data…Frequently asked questions about VIGL
What does Vigil Neuroscience, Inc. (VIGL) do?
Vigil Neuroscience, Inc., founded in 2020 and headquartered in Cambridge, Massachusetts, is a biotechnology company concentrating on microglia to develop transformative treatments for neurodegenerative diseases. The firm aims to provide disease-altering therapies for patients, their families, and caregivers affected by both rare and widespread n...
Where does VIGL trade?
Vigil Neuroscience, Inc. (VIGL) trades on the NASDAQ Global Select.
What sector is VIGL in?
Vigil Neuroscience, Inc. (VIGL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vigil Neuroscience, Inc.?
Ivana Magovcevic-Liebisch is the chief executive officer of Vigil Neuroscience, Inc. (VIGL).
Where is Vigil Neuroscience, Inc. headquartered?
Vigil Neuroscience, Inc. is headquartered in United States.
Does VIGL pay a dividend?
Vigil Neuroscience, Inc. (VIGL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VIGL go public?
Vigil Neuroscience, Inc. (VIGL) completed its initial public offering in 2022.